Goldman Sachs’s Solid Biosciences SLDB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.86M | Buy |
381,755
+201,618
| +112% | +$982K | ﹤0.01% | 3459 |
|
|
2025
Q1 | $667K | Buy |
180,137
+43,910
| +32% | +$162K | ﹤0.01% | 4085 |
|
|
2024
Q4 | $545K | Buy |
136,227
+26,629
| +24% | +$107K | ﹤0.01% | 4261 |
|
|
2024
Q3 | $764K | Buy |
109,598
+61,217
| +127% | +$427K | ﹤0.01% | 3906 |
|
|
2024
Q2 | $274K | Sell |
48,381
-155,367
| -76% | -$881K | ﹤0.01% | 4252 |
|
|
2024
Q1 | $2.71M | Buy |
+203,748
| New | +$2.71M | ﹤0.01% | 3007 |
|
|
2022
Q4 | – | Sell |
-9,337
| Closed | -$65K | – | 5331 |
|
|
2022
Q3 | $65K | Sell |
9,337
-16,198
| -63% | -$113K | ﹤0.01% | 5004 |
|
|
2022
Q2 | $236K | Buy |
25,535
+2,041
| +9% | +$18.9K | ﹤0.01% | 4828 |
|
|
2022
Q1 | $423K | Sell |
23,494
-8,817
| -27% | -$159K | ﹤0.01% | 4685 |
|
|
2021
Q4 | $848K | Buy |
32,311
+10,948
| +51% | +$287K | ﹤0.01% | 4166 |
|
|
2021
Q3 | $766K | Buy |
21,363
+17,670
| +478% | +$634K | ﹤0.01% | 4147 |
|
|
2021
Q2 | $203K | Sell |
3,693
-723
| -16% | -$39.7K | ﹤0.01% | 4910 |
|
|
2021
Q1 | $367K | Buy |
4,416
+963
| +28% | +$80K | ﹤0.01% | 4535 |
|
|
2020
Q4 | $392K | Sell |
3,453
-318
| -8% | -$36.1K | ﹤0.01% | 3957 |
|
|
2020
Q3 | $115K | Buy |
3,771
+183
| +5% | +$5.58K | ﹤0.01% | 4198 |
|
|
2020
Q2 | $158K | Sell |
3,588
-176
| -5% | -$7.75K | ﹤0.01% | 4065 |
|
|
2020
Q1 | $135K | Sell |
3,764
-1,746
| -32% | -$62.6K | ﹤0.01% | 4090 |
|
|
2019
Q4 | $368K | Sell |
5,510
-478
| -8% | -$31.9K | ﹤0.01% | 3785 |
|
|
2019
Q3 | $928K | Buy |
5,988
+3,429
| +134% | +$531K | ﹤0.01% | 3289 |
|
|
2019
Q2 | $221K | Buy |
2,559
+64
| +3% | +$5.53K | ﹤0.01% | 3832 |
|
|
2019
Q1 | $344K | Buy |
2,495
+1,003
| +67% | +$138K | ﹤0.01% | 3692 |
|
|
2018
Q4 | $600K | Buy |
1,492
+1,195
| +402% | +$481K | ﹤0.01% | 3340 |
|
|
2018
Q3 | $210K | Sell |
297
-78
| -21% | -$55.2K | ﹤0.01% | 3806 |
|
|
2018
Q2 | $201K | Buy |
+375
| New | +$201K | ﹤0.01% | 3880 |
|